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T
 
he
 
 observation that almost all malignant cancers
have telomerase activity has been explained by the
assumption that telomerase is crucial for the pro-
gression of malignancy. Surprisingly, cells from mice with-
out a functional telomerase RNA gene and no telomerase
activity are indistinguishable from normal cells in different
transformation and immortalization assays. However, de-
tailed analysis of chromosomes in telomerase null cells has
revealed multiple defects that point to the role of telo-
merase in normal biology and raise well-defined questions
for future research.
 
Telomere Biology
 
Telomeres are specialized structures at the end of chromo-
somes composed of DNA and proteins that are essential
for maintaining the stability of eukaryotic genomes (for
review see references 4, 34). The major functions of telo-
meres are (
 
a
 
) to protect chromosome ends from recombi-
nation, fusion, and degradation (cap function), (
 
b
 
) to posi-
tion and move chromosomes during various stages of the
meiotic and mitotic cell cycle (anchor function), and (
 
c
 
) to
counter telomere erosion resulting from incomplete repli-
cation of chromosome ends (end-replication “buffer” func-
tion). The latter is essential because conventional DNA
polymerases are unidirectional and cannot copy all bases
at the 3
 
9
 
 end of a linear duplex (33), resulting in the slow
loss of genetic material from the ends of chromosomes with
each replication round. In all vertebrates, including hu-
mans, the most terminal DNA consists of extended (up to
100 kb) arrays of TTAGGG repeats (26, 28), and the end-
replication “buffer” function is accomplished in two fun-
damentally different ways. In cells of the germ line and
most immortal cell lines, repeats are added to the 3
 
9
 
 end
by telomerase, a multimeric enzyme with reverse tran-
scriptase activity and an RNA template encoding for ter-
minal repeats (for review see reference 15). In most if not
all normal somatic cells, telomerase is either not expressed
or not capable of extending chromosome ends, and as a re-
sult, telomere repeats are lost with each replication round
(10, 13, 16, 19). A minimum telomere length appears to be
required to maintain the structural integrity of the chro-
mosomes. Shortening beyond this point has been impli-
cated in replicative senescence of cells (for review see ref-
erence 17), and (re)activation of functional telomerase has
been proposed as an important step in the development of
tumors (11, 20; for review see reference 31). In this sce-
nario, the loss of telomere repeats with each replication
round represents a mechanism to suppress the uncontrolled
proliferation of premalignant cells in long-lived species. 
 
Murine Models
 
The putative tumor-suppressor function and cell senes-
cence function of telomeres have long been challenged by
observations in the mouse (22; for review see reference
21). On average, telomeres are 5–10 times longer in mu-
rine cells than in human cells, and yet murine cells show
much more rapid senescence in culture. Nevertheless, like
in human cells, measurable telomerase activity is upregu-
lated in mouse tumors (3, 6, 7, 9), suggesting a role for telo-
merase in murine tumor formation after all. These and
other conflicting data have added to a large degree of con-
fusion regarding the role of telomeres and telomerase in
cellular senescence and tumor formation in mouse and
man. In view of this situation, data from mice without telo-
merase were eagerly awaited by investigators both inside
and outside the telomere field. Such data have now been
obtained by Blasco et al. (5), who developed mice in which
the telomerase RNA template gene has been removed
from the germ line using standard gene knock-out (KO)
 
1
 
techniques. The results obtained with (the cells from) the telo-
merase KO mice contain valuable lessons for anyone in-
terested in telomere biology.
 
The Hidden Phenotype of Telomerase KO Mice
 
As expected, no telomerase could be detected in cells de-
rived from homozygous KO animals, supporting the no-
tion of a single telomerase RNA gene in the murine ge-
nome. The fact that the KO mice were born alive and
apparently normal was the first surprise, since it indicates
that telomerase is not essential for maintaining telomeres
in somatic (stem) cells of renewing tissues such as skin, gut,
and blood during development and normal steady-state
tissue homeostasis. It has been suggested that cellular de-
fects may be demonstrated upon challenges to such tissues or
with aging of the mice (24), but details of such defects are
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currently not known. If the cells of self-renewing tissues
are affected, it will be important to distinguish between
the absence of telomerase and a decreased proliferative
potential (resulting from overall shorter telomeres; see be-
low) as primary defects. The observation that the telo-
merase null mice were fertile (resulting in multiple subse-
quent generations of KO animals) was the second surprise,
initially suggesting that telomerase was not necessary to
maintain telomeres in the germ line. Furthermore, cells from
telomerase-deficient mice were as efficiently transformed
into immortal and in vivo tumor-forming cells as cells from
telomerase-positive animals, demonstrating conclusively
that, in the mouse, telomerase is not an essential require-
ment for the establishment of cell lines, oncogenic trans-
formation, or tumor formation. The surprises did not end
there. All of the above could still be explained by assum-
ing that telomere shortening was perhaps occurring at a
very slow rate in cells known to have very long initial telo-
meres (22), perhaps together with alternative pathways for
telomere maintenance in immortal tumor cells (see be-
low). The studies by Blasco et al. (5) have revealed that the
situation is more complex. Continued inbreeding has pro-
duced up to six generations of KO animals. Although con-
ventional telomere length analysis by Southern essentially
failed to detect telomere shortening, clear differences in telo-
mere length between cells from subsequent generations of
KO animals were observed using quantitative fluorescence
in situ hybridization (Q-FISH) (25, 36). The Q-FISH obser-
vations on the ends of individual chromosomes in telo-
merase KO cells has provided some answers to several of
the long-standing questions about telomeres in the mouse
and provide a focus for future studies. Such observations
are summarized below.
 
Germ Cells Need Telomerase to Maintain
Telomere Length
 
The first lesson from Q-FISH is that telomerase is essen-
tial to maintain telomere length in the germ line. Without
telomerase, telomere repeats are lost at a variable rate of
2–7 kb per generation of mice. Assuming a loss of 75–150
or 100 bp/cell division (1, 16, 29), this translates into 20–70
cell divisions from germ cell to germ cell in subsequent
generations of animals. It has been estimated that sperm
cells undergo an average of 62 cell divisions from the zy-
gote, whereas from zygote to oocyte takes on average only
25 divisions (14). The agreement between experimental
data and theoretical predictions is striking and strongly
supports the original suggestion that telomere shortening
in somatic cells results from the absence of telomerase in
such cells (10).
 
Uncapped Chromosomes?
 
The next surprise is related to telomeres apparently lack-
ing TTAGGG repeats altogether. Chromosomes without
detectable TTAGGG on at least one end were observed at
increased frequencies from generation 2 and higher (sev-
eral per metaphase spread in later generations). That such
ends are unstable is demonstrated by the increasing fre-
quency of aneuploid cells and end-to-end associations of
chromosomes with each subsequent generation of the KO
mice. This observation provides direct and formal proof
that chromosome ends without TTAGGG are unstable and
predisposed to chromosomal abnormalities, as was pre-
dicted (18; for review see reference 12). More surprising is
that such uncapped ends are so readily observed. Using
plasmids with TTAGGG inserts of variable size, the sensi-
tivity of Q-FISH for the detection of TTAGGG repeats
has been determined to be in the order of a few hundred
base pairs or less (36). If sensitivity is similar for chromo-
somes in metaphase spreads, ends without detectable
Q-FISH signals may contain less than a few hundred base
pairs of TTAGGG. What is the history and what are the
implications of such apparently uncapped chromosome
ends? Did or do such ends signal a prolonged but transient
cell cycle arrest as in yeast (see below), or are they at least
temporarily ignored, perhaps similarly to uncapped ends
of 
 
Drosophila
 
 chromosomes (27)? If loss of TTAGGG by
itself is not sufficient to make chromosomes become fuso-
genic and/or recombinogenic, what other factors are in-
volved in this transition? 
 
Uncapped Chromosomes: Are Adaptive
Responses Involved?
 
It has been shown that a single break at the end of a yeast
chromosome will trigger a 
 
RAD9
 
-mediated cell cycle arrest
(30). Interestingly, in that study many of the yeast cells re-
covered from the initial arrest without repairing the dam-
aged chromosome and resumed cell divisions. Although
uncapped chromosomes in yeast were destined for even-
tual loss, they were apparently no longer recognized by the
 
RAD9
 
 pathway, or this pathway was shut off. A similar ad-
aptation of signal transduction systems may apply to cells
of telomerase KO mice. It is possible that cells without
TTAGGG on one or more chromosomes, perhaps also after
a transient cell cycle arrest, adapted to signaling by uncapped
chromosomes, and this possibility warrants further investi-
gation. In any event, it seems that murine cells with one or
more uncapped chromosomes can divide for many times
with or without an initial arrest. Indeed, normal develop-
ment and even fertility does not seem to be immediately
affected by the presence of such uncapped chromosomes. 
 
Telomere Elongation by Recombination?
 
Conceivably, chromosomes without TTAGGG repeats could
also be “healed” by recombinational repair. Based on stud-
ies of yeast (for review see reference 35), many alternative
scenarios for recombinational telomere repair are possi-
ble. Uncapped chromosomes in yeast can acquire a new
telomere by homologous recombination, both reciprocal
and nonreciprocal, via 
 
RAD52
 
-mediated gene conversion
(32). Nonreciprocal recombination or gene conversion be-
tween telomeres on homologous or nonhomologous chro-
mosomes (as depicted in Fig. 1) could occur in mammalian
cells as well. Indeed, the overall long telomeres in the
mouse could favor the use of such a nonreciprocal recom-
bination: a critically short telomere in a murine cell could
perhaps easily recombine with remaining long telomeres
on other chromosomes. As the overall telomere length de-
creases in subsequent generations of the telomerase KO
animals, the efficiency of this pathways could decrease, pos-
sibly with the increased frequencies of chromosomal ab-
normalities seen at later generations as a result.  
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Chromosomal Abnormalities in Telomerase KO Cells
 
The presence of the Robertsonian fusions observed in
later generations of the telomerase KO mice deserves spe-
cial mention (Fig. 2). Given that telomeres on the short
 
 P
 
arm of acrocentric murine chromosomes are, in general, sig-
nificantly shorter than q arm telomeres (36), a gradual loss
of telomere repeats would be expected to predispose to this
type of chromosomal abnormality. Are the Robertsonian
chromosomes in the telomerase KO mouse stable? If the
primary fusion event was indeed between two different un-
capped chromosomes, the prediction would be that they
are not, as such chromosomes are expected to have two
functional centromeres (23). Further studies of these Rob-
ertsonian chromosomes should reveal whether they represent
unique cytogenetic abnormalities in telomerase KO mice.
 
Implications for Models of Tumor Growth and 
Telomerase Inhibition Therapy 
 
The observation that telomerase appears completely dis-
pensable for tumorigenesis in the mouse should be dis-
cussed in relation to models of tumor cell proliferation and
the possible use of telomerase inhibitors in cancer therapy
(17). Approximately a quarter of immortalized human cell
lines lack detectable telomerase activity (for review see
reference 8), indicating that alternatives to telomerase for
the maintenance of telomeres also exist in human cells. Fur-
thermore, evidence is accumulating that in different so-
matic cell types, including tumor cells, telomerase may be
best correlated with proliferation rate as telomeres con-
tinue to shorten in many telomerase-positive cells (re-
Figure 1. Pathways to maintain telomere length. Telomerase, a
reverse transcriptase, can extend the 39 end of telomeres using an
RNA component complimentary to the G-rich repeats of the 39
strand. Are recombination pathways important to maintain telo-
mere length in telomerase KO mice? Shown is nonreciprocal re-
combination proposed for telomere elongation in yeast (32).
Continued shortening of telomeres and abundant chromosome
ends without detectable telomere repeats in cells from telo-
merase KO mice suggest that such recombination pathways are
either unable to prevent overall telomere loss or are not active at
all. Each box represents a repeat unit. Hatched boxes represent
newly synthesized repeats. The figure was adapted from refer-
ence 32.
Figure 2. Chromosomal ab-
normalities in embryonic fi-
broblasts derived from the
sixth generation of telomerase
null mice. Results were ob-
tained by Q-FISH using pep-
tide nucleic acid (PNA) probes
as described (25, 36). Yellow
and orange represent telo-
mere signals obtained with
Cy3-labeled (CCCTAA)3
PNA, and blue represents
DAPI-stained chromosomal
DNA. Pseudocolors were as-
signed using Adobe Photo-
shop software (San Jose, CA).
Asterisks indicate metacentric
Robertsonian fusion prod-
ucts between acrocentric chro-
mosomes. Number signs indi-
cate chromosome arms without
detectable TTAGGG repeats. 
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viewed in 2). Apparently, measurable enzyme activity is
frequently not associated with elongation or static mainte-
nance of telomere length, perhaps because telomeres are
inaccessible to telomerase in most somatic and tumor cells.
The observations with the telomerase KO mice clearly
show that telomere shortening, lack of telomerase, and
even uncapped chromosomes are not incompatible with
continued and extensive proliferation. However, caution
in the extrapolation of the murine data to the human situa-
tion is warranted, in view of the well-known observation
that human cells are less efficiently immortalized than mu-
rine cells. Could less efficient adaptive responses and/or
recombination (as shown in Fig. 1) explain the differences
in immortalization rates between the species? The obser-
vation that cells from 
 
M. spretus
 
 (with telomeres of com-
parable length to human cells) will spontaneously, be it less
efficiently, immortalize in culture (29) indicates that over-
all telomere length cannot be a major factor predisposing
cells towards spontaneous immortalization. Differences in
the signaling and/or processing of critically short telo-
meres between murine and human cells could conceivably
make continued proliferation in human cells more depen-
dent on telomerase. In general, many questions about the
role of telomerase and recombination pathways in the pro-
liferation, senescence, and immortalization of normal and
malignant cells from different murine and human tissues
remain. For this reason caution in extrapolating findings
with murine cells too directly to human cells remains war-
ranted. However, with the current rate of progress, an-
swers to many of these questions should be available in the
near future.
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